Effects of quercetin and artemetin prenylation on bioavailability and bioactivity.


Journal

Chemistry and physics of lipids
ISSN: 1873-2941
Titre abrégé: Chem Phys Lipids
Pays: Ireland
ID NLM: 0067206

Informations de publication

Date de publication:
10 2021
Historique:
received: 14 07 2021
revised: 09 09 2021
accepted: 09 09 2021
pubmed: 17 9 2021
medline: 28 12 2021
entrez: 16 9 2021
Statut: ppublish

Résumé

Flavonoids are a huge class of polyphenolic compounds ubiquitous in higher plants, in most food and beverages of natural origin. They could be considered as dietary phenols, which exert many health-promoting effects on human and animal physiology with a wide range of biomedical and nutritional functions such as activation or inhibition of enzymes like lipoxygenase and cyclooxygenase, the detoxification of carcinogens and chemoprevention. From a chemical point of view, these aromatic compounds can be divided in six subgroups depending on the position of aromatic B ring on C ring, the degree of unsaturation and oxidation, the position of hydroxyl groups and their functionalization. Between flavonoids, the prenylated ones represent a unique class occurring in nature where the C-prenylation is the most common, whereas O-prenylation is rarely present. The presence of this lipophilic functional group in different positions on the scaffold of flavonoids can sometimes lead to relevant changes in their biological activity due to an increased bioavailability. Capitalizing on the restricted incidence in nature of prenylated flavonoids, we have assessed the synthesis of C- and O-prenylated derivatives starting from two flavonoids, quercetin and artemetin, aimed at the exploration of structure-activity relationships. Results showed that prenylation significantly increased the cytotoxic effect of flavonoids in cancer HeLa cells, also improving their capacity to affect cell phospholipid and fatty acid composition. A marked cell bioavailability increase was demonstrated for the artemetin C-prenylated derivative.

Identifiants

pubmed: 34529978
pii: S0009-3084(21)00090-6
doi: 10.1016/j.chemphyslip.2021.105137
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Flavonoids 0
artemetin 73KMT7R64H
Quercetin 9IKM0I5T1E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105137

Informations de copyright

Published by Elsevier B.V.

Auteurs

Stefano Salamone (S)

Dip. Di Scienze del Farmaco, Università del Piemonte Orientale, l̥Largo Donegani 2/3, 28100 Novara, Italy.

Mariella Nieddu (M)

Dip. di Scienze Biomediche, Università degli Studi di Cagliari, Cittadella Universitaria, l̥SS 554, Km 4.5, 09042 Monserrato, Cagliari, Italy.

Adil Khalili (A)

Dip. Di Scienze del Farmaco, Università del Piemonte Orientale, l̥Largo Donegani 2/3, 28100 Novara, Italy.

Andrea Sansaro (A)

Dip. Di Scienze del Farmaco, Università del Piemonte Orientale, l̥Largo Donegani 2/3, 28100 Novara, Italy.

Ezio Bombardelli (E)

Plantex S.a.s., Galleria Unione 5, 20122 Milano, Italy.

Antonella Rosa (A)

Dip. di Scienze Biomediche, Università degli Studi di Cagliari, Cittadella Universitaria, l̥SS 554, Km 4.5, 09042 Monserrato, Cagliari, Italy. Electronic address: federica.pollastro@uniupo.it.

Federica Pollastro (F)

Dip. Di Scienze del Farmaco, Università del Piemonte Orientale, l̥Largo Donegani 2/3, 28100 Novara, Italy; PlantaChem S.R.L.S., l̥via Amico Canobio 4/6, 28100 Novara, Italy. Electronic address: federica.pollastro@uniupo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH